Cargando…
Using Health Economics to Inform Immunization Policy Across All Levels of Government
Publicly funded immunization programs have grown in both complexity and scope, resulting in increased costs and more complex programmatic decision making. Economic evaluations can provide crucial information to support informed decision making. While very few countries have National Immunization Tec...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440180/ https://www.ncbi.nlm.nih.gov/pubmed/35829929 http://dx.doi.org/10.1007/s41669-022-00347-1 |
_version_ | 1784782280101724160 |
---|---|
author | Rafferty, Ellen Reifferscheid, Laura Assi, Ali MacDonald, Shannon E. |
author_facet | Rafferty, Ellen Reifferscheid, Laura Assi, Ali MacDonald, Shannon E. |
author_sort | Rafferty, Ellen |
collection | PubMed |
description | Publicly funded immunization programs have grown in both complexity and scope, resulting in increased costs and more complex programmatic decision making. Economic evaluations can provide crucial information to support informed decision making. While very few countries have National Immunization Technical Advisory Groups that analyze economic information, many have started to develop processes for this purpose. Since these guidelines are being developed at the national level, we propose that regional jurisdictions, especially those responsible for healthcare (e.g., provinces, territories, states), need clear processes for incorporating this information into their immunization decision making and program implementation. We interviewed Canadian vaccine experts involved in provincial vaccine policy decision making to identify current practices, perceptions, and recommendations around incorporating economic analysis into that process. Based on these interviews, we make five recommendations: (1) economic evidence should be routinely incorporated into the decision making process; (2) economic experts should sit on, or be available to, regional advisory committees; (3) efforts should be made to build on regional expertise by increasing educational opportunities on economic evaluation; (4) processes should include guidelines for when economic analysis is not required; and (5) clarification on the role of regional advisory groups in economic analysis is needed in relation to national expertise. The information presented here provides a starting point for regional health policy experts and decision makers to work collaboratively with national partners to create transparent and effective approaches to incorporating economic analysis into vaccine decision making. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s41669-022-00347-1. |
format | Online Article Text |
id | pubmed-9440180 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-94401802022-09-04 Using Health Economics to Inform Immunization Policy Across All Levels of Government Rafferty, Ellen Reifferscheid, Laura Assi, Ali MacDonald, Shannon E. Pharmacoecon Open Current Opinion Publicly funded immunization programs have grown in both complexity and scope, resulting in increased costs and more complex programmatic decision making. Economic evaluations can provide crucial information to support informed decision making. While very few countries have National Immunization Technical Advisory Groups that analyze economic information, many have started to develop processes for this purpose. Since these guidelines are being developed at the national level, we propose that regional jurisdictions, especially those responsible for healthcare (e.g., provinces, territories, states), need clear processes for incorporating this information into their immunization decision making and program implementation. We interviewed Canadian vaccine experts involved in provincial vaccine policy decision making to identify current practices, perceptions, and recommendations around incorporating economic analysis into that process. Based on these interviews, we make five recommendations: (1) economic evidence should be routinely incorporated into the decision making process; (2) economic experts should sit on, or be available to, regional advisory committees; (3) efforts should be made to build on regional expertise by increasing educational opportunities on economic evaluation; (4) processes should include guidelines for when economic analysis is not required; and (5) clarification on the role of regional advisory groups in economic analysis is needed in relation to national expertise. The information presented here provides a starting point for regional health policy experts and decision makers to work collaboratively with national partners to create transparent and effective approaches to incorporating economic analysis into vaccine decision making. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s41669-022-00347-1. Springer International Publishing 2022-07-13 /pmc/articles/PMC9440180/ /pubmed/35829929 http://dx.doi.org/10.1007/s41669-022-00347-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Current Opinion Rafferty, Ellen Reifferscheid, Laura Assi, Ali MacDonald, Shannon E. Using Health Economics to Inform Immunization Policy Across All Levels of Government |
title | Using Health Economics to Inform Immunization Policy Across All Levels of Government |
title_full | Using Health Economics to Inform Immunization Policy Across All Levels of Government |
title_fullStr | Using Health Economics to Inform Immunization Policy Across All Levels of Government |
title_full_unstemmed | Using Health Economics to Inform Immunization Policy Across All Levels of Government |
title_short | Using Health Economics to Inform Immunization Policy Across All Levels of Government |
title_sort | using health economics to inform immunization policy across all levels of government |
topic | Current Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440180/ https://www.ncbi.nlm.nih.gov/pubmed/35829929 http://dx.doi.org/10.1007/s41669-022-00347-1 |
work_keys_str_mv | AT raffertyellen usinghealtheconomicstoinformimmunizationpolicyacrossalllevelsofgovernment AT reifferscheidlaura usinghealtheconomicstoinformimmunizationpolicyacrossalllevelsofgovernment AT assiali usinghealtheconomicstoinformimmunizationpolicyacrossalllevelsofgovernment AT macdonaldshannone usinghealtheconomicstoinformimmunizationpolicyacrossalllevelsofgovernment |